Boston Scientific to stop heart device sales amid regulatory challenges

Boston Scientific said on Wednesday it has discontinued sales of its heart device in the European Union and will not seek approval in the U.S. and other markets due to increased clinical and ... Read More

Boston Scientific lifts sales outlook, notes key approval of AFib ...

Boston Scientific lifts sales outlook, notes key approval of AFib device with Minnesota ties The med-tech company with approximately 9,400 employees in Minnesota posted profit and sales that beat ... Read More

Boston Scientific to buy Relievant Medsystems for at least $850M

13 Hours ago Hurricane Kristy strengthens into a Category 4 storm in the Pacific Ocean 14 Hours ago Boston Scientific lifts sales outlook, notes key approval of AFib device with Minnesota ties ... Read More

Boston Scientific Beats Forecasts, Boosts Outlook on Booming Heart ...

Boston Scientific exceeded first-quarter profit and sales forecasts on demand for its cardiovascular devices. The results were lifted by regulatory approval and launch of its product to treat ... Read More

Boston Scientific lifts annual profit forecast, pauses heart device ...

Boston Scientific increased its annual profit forecast on Wednesday, fueled by strong demand for its cardiac implants, but temporarily halted a pivotal heart equipment study citing unexpected events. Read More

Truist lifts Boston Scientific stock target to $120, maintains Buy - MSN

On Thursday, Truist Securities expressed a positive outlook on Boston Scientific (NYSE:BSX) shares, raising the price target to $120 from $110, while reaffirming a Buy rating. The stock, currently ... Read More

Boston Scientific Profit and Sales Are Boosted by Cardiovascular Device ...

Boston Scientific's second-quarter earnings and revenue got a boost from high demand for its heart devices. Sales of cardiovascular products made up more than half of the company's revenue in the ... Read More

Boston Scientific Raises Annual Outlook After Strong Heart ... - Benzinga

Boston Scientific topped Q1 revenue and EPS forecasts, lifted its 2025 outlook, and announced CFO Dan Brennan's retirement after nearly 30 years. Read More

Boston Scientific to buy Minnesota company - The Boston Globe

Boston Scientific Corp. has reached a deal to buy Relievant Medsystems, a Minnesota-based maker of devices that treat chronic low back pain, with an upfront cash payment of $850 million and ... Read More

Boston Scientific lifts earnings forecast on solid demand for heart devices

(Reuters) -Boston Scientific raised its annual profit forecast on Thursday, banking on strong demand for heart devices including its stroke prevention product, Watchman, and a recovery in demand ... Read More

Boston Scientific Gets FDA Approval For Expanded Labeling Of WATCHMAN ...

(RTTNews) - Medical technology company Boston Scientific Corp. (BSX) announced Tuesday that it has received U.S. Food and Drug Administration approval for expanded labeling of WATCHMAN FLX Left ... Read More

Boston Scientific Beats Forecasts, Boosts Outlook on Booming ... - MSN

Key Takeaways Boston Scientific exceeded first-quarter profit and sales forecasts on demand for its cardiovascular devices.The results were lifted by regulatory approval and launch of its product ... Read More